Showing results 56 to 75 of 87
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2014 | Pharmacogenomics of methadone maintenance treatment | Somogyi, A.; Barratt, D.; Ali, R.; Coller, J. |
| 2009 | Pharmacology of opioid agonists and antagonists | Gordon, A.; Hutchinson, M.; La Vincente, S.; Mitchell, T.; Morrish, G.; Newcombe, D.; Somogyi, A.; White, J.; Mattick, R.; Ali, R.; Lintzeris, N. |
| 2009 | Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines | Mattick, R.; Ali, R.; Lintzeris, N. |
| 2011 | Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing | Larance, B.; Degenhardt, L.; Lintzeris, N.; Bell, J.; Winstock, A.; Dietze, P.; Mattick, R.; Ali, R.; Horyniak, D. |
| 2012 | Predictive factors for treatment retention in methadone programs in Indonesia | Sarasvita, R.; Tonkin, A.; Utomo, B.; Ali, R. |
| 2008 | Pregnancy-related changes in tobacco, alcohol and cannabis use reported by antenatal patients at two public hospitals in South Australia | Hotham, E.; Ali, R.; White, J.; Robinson, J. |
| 2011 | Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients | Larance, B.; Degenhardt, L.; O'Brien, S.; Lintzeris, N.; Winstock, A.; Mattick, R.; Bell, J.; Ali, R. |
| 2003 | Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia | Humeniuk, R.; Ali, R.; McGregor, C.; Darke, S. |
| 2003 | Psychotic symptoms in methamphetamine psychotic in-patients | Srisurapanont, M.; Ali, R.; Marsden, J.; Sunga, A.; Wada, K.; Monteiro, M. |
| 2002 | Relationship between LAAM-methadone preference and treatment outcomes | White, J.; Danz, C.; Kneebone, J.; La Vincente, S.; Newcombe, D.; Ali, R. |
| 2002 | Reply to Dr. Clark's comment on Doverty et al., hyperalgesic responses in methadone maintenance patients (Pain 2001;90 : 91-96) | Doverty, M.; White, J.; Somogyi, A.; Bochner, F.; Ali, R.; Ling, W. |
| 2021 | Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomes | Jones, N.R.; Nielsen, S.; Farrell, M.; Ali, R.; Gill, A.; Larney, S.; Degenhardt, L. |
| 2012 | Screening for use of alcohol, tobacco and cannabis in pregnancy using self-report tools | Hotham, E.; White, J.; Ali, R.; Robinson, J. |
| 2009 | Services for heroin withdrawal: A review | Lintzeris, N.; Gowing, L.; Bell, J.; Mattick, R.; Ali, R.; Lintzeris, N. |
| 2005 | Short-term outcomes of five heroin detoxification methods in the Australian NEPOD project | Digiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J. |
| 2008 | Substitution treatment of injecting opioid users for prevention of HIV infection | Gowing, L.; Farrell, M.; Bornemann, R.; Sullivan, L.; Ali, R.; Gowing, L. |
| 2000 | Systematic review processes and the management of opioid withdrawal | Gowing, L.; Ali, R.; White, J. |
| 2002 | The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility | Ali, R.; Awwad, E.; Babor, T.; Bradley, F.; Butau, T.; Farrell, M.; Formigoni, M.; Isralowitz, R.; Boerngen de Lacerda, R.; Marsden, J.; McRee, B.; Monteiro, M.; Pal, H.; Rubio-Stipec, M.; Vendetti, J.; Ali, Robert Leonard |
| 2015 | The characteristics of a cohort who tamper with prescribed and diverted opioid medications | Larance, B.; Lintzeris, N.; Bruno, R.; Peacock, A.; Cama, E.; Ali, R.; Kihas, I.; Hordern, A.; White, N.; Degenhardt, L. |
| 2005 | The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS) | Ross, J.; Teesson, M.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R. |
